Cannabidiol Market Share, Size, Trends, Industry Analysis Report, By Product (CBD Oil, CBD Isolates, CBD Concentrates, Others); By Application (Dietary Supplements, Pharmaceutical, Topicals, Tincture, Food, Beverages, Others); By Source; By Region; Segmen

The global cannabidiol market size is expected to reach USD 43.66 billion by 2034, according to a new study by Polaris Market Research. The report “Cannabidiol Market Share, Size, Trends, Industry Analysis Report, By Product (CBD Oil, CBD Isolates, CBD Concentrates, Others); By Application (Dietary Supplements, Pharmaceutical, Topicals, Tincture, Food, Beverages, Others); By Source; By Region; Segment Forecast, 2025 - 2034” provides detailed insight into current market dynamics and analysis of future market growth.

increasing demand for CBD oil in the manufacture of pharmaceuticals due to its pain-relieving properties, has fueled the development of the cannabidiol oil industry in recent years. Growing awareness of CBD's therapeutic potential increased, and shoppers began buying cannabidiol products nevertheless of the high cost associated with it.

Industry participants are concentrating on promoting cannabis-based products as they offer massive business opportunities and vital profit margins. CBD is trusted to have great medicinal properties for annexed caused by paroxysms and related disorders.

Global demand for nutritious and nutritious food products is enhanced with vital nutrients for carrying out fitness aims and keeping away from diseases such as pain, soreness, sensitivity, restlessness, and others. Major manufacturers in the CBD industry are aiming to launch new products prepared with CBD oil.

CBD oil is a government-approved/legal and non-hallucinogenic constituent of hemp, which can be applied in multiple sectors, likely pharmaceuticals, health, food, and cosmetic products.

The industry has begun observing a scarcity of raw materials and other needful product supplies because of the countrywide closedown of shipments and fabrication hubs in many emerging economies, such as Brazil, China, South Korea, and India. Additionally, as a consequence of demand-supply system obstructions in North America and Europe, the provisioning of primary raw materials has been narrowed, which is hampering the manufacturing process, and as a result, the supply chain of the CBD industry.

Cannabidiol Market Report Highlights

The marijuana segment dominated the industry in 2024 owing to the growing adoption of CBD products and the surge in the legitimization of marijuana for several medical purposes.

The usage of hemp-obtain CBD is gaining acceptance due to its anti-aging, anti-inflammatory, and antioxidant attributes, further sectors such as personal care, therapeutics, nutraceuticals, food & beverages, wellness products, and cosmetics are producing CBD products.

The pharmaceuticals section dominated the market in 2024 due to the rising digit of in-progress R&D to examine the consequences of CBD on individual health expected to drive the growth of the industry.

North American region is expected to lead the industry during the forecast period and will continue its dominance owing to the existence of a big number of health-conscious citizens, booming adoption of CBD products, and the presence of key players.

The global players include Cannoid, Inc., Medical Marijuana, Inc., NuLeaf Naturals, Folium Biosciences, Elixinol, Pharmahemp, Isodiol International, ENDOCA, and Others.

Polaris Market Research has segmented the cannabidiol market report based on by product type, application, source, and region:

Cannabidiol (CBD), Product Type Outlook (Revenue - USD Billion, 2020 - 2034)

CBD Oil

CBD Isolates

CBD Concentrates

Others

Cannabidiol (CBD), Application Outlook (Revenue - USD Billion, 2020 - 2034)

Dietary Supplements

Pharmaceutical

Topicals

Tincture

Food

Beverages

Others

Cannabidiol (CBD), Source Outlook (Revenue - USD Billion, 2020 - 2034)

Marijuana

Hemp

Cannabidiol (CBD), Regional Outlook (Revenue - USD Billion, 2020 - 2034)

North America

U.S

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa Show more